Veres Diagnostics, LTD

Veres Diagnostics, LTD was paid $234K by Medicaid between Jan 2018 and Mar 2023, across 41 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 29% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#66 of 108

Median peer was paid$588K

This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,162	$19K
2019	1,619	$10K
2020	776	$17K
2021	3,552	$110K
2022	2,637	$72K
2023	168	$6K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	29%	1,105	601	$68K
86769		14%	673	544	$33K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	12%	1,844	1,137	$29K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	10%	242	242	$24K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	8.4%	1,052	572	$20K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	5.9%	399	249	$14K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.5%	280	275	$6K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.3%	272	267	$5K
84443	Thyroid stimulating hormone (TSH)	2.2%	474	466	$5K
80053	Comprehensive metabolic panel	1.7%	483	472	$4K
83036	Hemoglobin; glycosylated (A1C)	1.4%	449	442	$3K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.2%	531	515	$3K

29 more codes

80061	Lipid panel	1.1%	252	$3K
83735		<1%	483	$2K
86328		<1%	64	$2K
83721		<1%	274	$2K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	221	$2K
87631		<1%	14	$1K
83695		<1%	107	$1K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	341	$1K
84550		<1%	254	$807.56
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	39	$600.56
80164		<1%	45	$595.12
82172		<1%	104	$473.90
82570		<1%	109	$408.77
82728		<1%	40	$351.25
87428		<1%	14	$342.15
84152		<1%	15	$314.76
84154		<1%	15	$282.00
83550		<1%	40	$225.21
81000		<1%	68	$169.76
82043		<1%	54	$167.05
83540		<1%	40	$166.74
87471		<1%	14	$116.20
82465		<1%	50	$113.35
83690		<1%	13	$84.60
82150		<1%	13	$79.44
82977		<1%	14	$63.75
82248		<1%	14	$44.49
36415	Collection of venous blood by venipuncture	<1%	386	$5.40
83883		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVAJENINE, ALEXEI (MEDICAL DIRECTOR)